Canada Pension Plan Investment Board’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Canada Pension Plan Investment Board’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-100,000	Closed	-$1.25M	–	1574
2019 Q1	$1.25M	Buy	100,000 +25,000	+33%	+$334K	﹤0.01%	1078
2018 Q4	$849K	Buy	+75,000	New	+$1.18M	﹤0.01%	1100
2017 Q2	–	Sell	-75,000	Closed	-$2.02M	–	1183
2017 Q1	$2.02M	Buy	+75,000	New	+$1.53M	0.01%	802

Other funds holding FLXN

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Canada Pension Plan Investment Board's FLXN Position: Q2 2019 in Review

Canada Pension Plan Investment Board sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2019, closing a stake of 100,000 shares — an estimated $1.25M sold.

Canada Pension Plan Investment Board first reported a position in FLXN in Q1 2017 and held it in 3 quarters. The position peaked at $2.02M in Q1 2017. 129 funds tracked by Wall St. Rank hold FLXN as of Q2 2019.

Canada Pension Plan Investment Board reported no remaining Flexion Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Canada Pension Plan Investment Board sold 100,000 Flexion Therapeutics, Inc. shares in Q2 2019, an estimated $1.25M.
Canada Pension Plan Investment Board first reported a position in Flexion Therapeutics, Inc. in Q1 2017 and held it in 3 quarters.
Canada Pension Plan Investment Board's Flexion Therapeutics, Inc. position peaked at $2.02M in Q1 2017.
129 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2019.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2019, filed 12 Aug 2019.